1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Leukemia-Lymphoma, Adult T-Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bazan, NG; Block, AL; Braquet, P; Squinto, SP | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Leukemia-Lymphoma, Adult T-Cell
| Article | Year |
|---|---|
Platelet-activating factor activates HIV promoter in transfected SH-SY5Y neuroblastoma cells and MOLT-4 T lymphocytes.
Topics: Acquired Immunodeficiency Syndrome; Animals; Drug Design; Gene Expression Regulation, Viral; Genes, Viral; HIV; Humans; Leukemia-Lymphoma, Adult T-Cell; Neuroblastoma; Platelet Activating Factor; Promoter Regions, Genetic; Recombinant Fusion Proteins; Repetitive Sequences, Nucleic Acid; Stimulation, Chemical; T-Lymphocytes; Transfection; Tumor Cells, Cultured | 1990 |